Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitreous Levels of Acular LS, Xibrom, and Nevanac in Vitrectomy
NCT00377546Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nepafenac, ketorolac, bromfenac sodium in post-operative ocular inflammation, sponsored by Janssen Pharmaceutical. Status: completed.
02
Drugs
nepafenacketorolacbromfenac sodium
03
Conditions
post-operative ocular inflammation
Beyond the preview
Go deeper on NCT00377546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00377546.